Back to
VANGUARD GROUP INC
AEON2 quarters
Position history for
VANGUARD GROUP INC's holdings in AEON BIOPHARMA INC
As of its last 13F, for Q4 2025, Vanguard Group held 100,333 shares of AEON (Aeon Biopharma), worth $110,366. It increased the position by 1,765 shares (+1.8%) from Q3 2025. Vanguard Group held AEON from Q3 2025 to Q4 2025, across 2 quarterly 13F filings.
Current Value
$110,366
Current Shares
100,333
Total Value Change
+$30,624
Total Shares Change
+1,765
Quarter-by-Quarter History
Other major holders of AEON: VANGUARD CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC